The lengthy mobilization of the UFC-Que Choisir can have ended up paying off: the decree on drug stocks was lastly revealed this Wednesday, March 31. However, the too restricted length of stocks tarnishes the image; the textual content misses its goal of actually securing entry to medicines in tight provide conditions.
I had already had the alternative to denounce the ignition delay for the publication of this Decree. The legislation, nonetheless handed at the finish of 2019, met the frank opposition of producers who had threatened to produce the French market much less nicely. Indeed, the structure of stocks will henceforth be their duty, an obligation badly lived by an business which generally appears extra connected to the seek for the least value than to the safety of public well being. The stress from the laboratories had reached its paroxysm in Brussels, resulting in the blocking of the textual content for a lot of months by the European Commission, on the grounds of obstructing the free motion of products …
The Decree is lastly revealed! I can solely welcome its publication due to the robust sign it sends: the battle towards drug shortages essentially entails increase stocks. This measure have to be supposed to increase to Europe, since it’s by means of substantial European stocks that the Old Continent will have the ability to defend itself towards the disastrous results of recurrent shortages.
But studying this textual content can not fail to go away a style of unfinished enterprise. First of all, solely medication of main therapeutic curiosity are in actual fact involved by stocks. Above all, the protection of consumer wants is proscribed to 2 months, which is notoriously inadequate after we know that the shortages final on common 14 weeks. To guarantee everybody’s entry to therapy, the UFC-Que Choisir campaigned, with different consumer associations, for the structure of not less than 4 months of stocks. Today we’re far from the mark!
With the publication of the inventory decree, it’s subsequently a first step that has been taken in favor of customers. In order for it to represent actual progress by way of public well being, I name for a strengthening of controls and really dissuasive sanctions for recalcitrant producers. Finally, I name as soon as once more for the public authorities to bear in mind: the lack of ambition severely undermines the battle towards drug shortages!